MedKoo Cat#: 414476 | Name: Norfluoxetine Free Base
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Norfluoxetine Free Base is a metabolite of fluoxetine.

Chemical Structure

 Norfluoxetine Free Base
Norfluoxetine Free Base
CAS#83891-03-6 (free base)

Theoretical Analysis

MedKoo Cat#: 414476

Name: Norfluoxetine Free Base

CAS#: 83891-03-6 (free base)

Chemical Formula: C16H16F3NO

Exact Mass: 295.1184

Molecular Weight: 295.30

Elemental Analysis: Chemical Formula: Exact Mass: Molecular Weight: Elemental Analysis: C, 65.08; H, 5.46; F, 19.30; N, 4.74; O, 5.42

Price and Availability

Size Price Availability Quantity
5g USD 3,680.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Synonym
Norfluoxetine Free Base; Desmethylfluoxetine
IUPAC/Chemical Name
Benzenepropanamine, gamma-(4-(trifluoromethyl)phenoxy)-
InChi Key
WIQRCHMSJFFONW-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H16F3NO/c17-16(18,19)13-6-8-14(9-7-13)21-15(10-11-20)12-4-2-1-3-5-12/h1-9,15H,10-11,20H2
SMILES Code
NCCC(OC1=CC=C(C(F)(F)F)C=C1)C2=CC=CC=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 295.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Altamura AC, Moro AR, Percudani M. Clinical pharmacokinetics of fluoxetine. Clin Pharmacokinet. 1994 Mar;26(3):201-14. doi: 10.2165/00003088-199426030-00004. PMID: 8194283. 2: Dhami KS, Churchward MA, Baker GB, Todd KG. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. J Neurochem. 2019 Mar;148(6):761-778. doi: 10.1111/jnc.14661. Epub 2019 Feb 12. PMID: 30613984. 3: Rodrigues P, Cunha V, Oliva-Teles L, Ferreira M, Guimarães L. Effects of norfluoxetine and venlafaxine in zebrafish larvae: Molecular data. Data Brief. 2020 Nov 10;33:106515. doi: 10.1016/j.dib.2020.106515. PMID: 33294513; PMCID: PMC7689041. 4: Över SB, Güven C, Taskin E, Sevgiler Y. Oxidative and apoptotic effects of fluoxetine and its metabolite norfluoxetine in Daphnia magna. Arh Hig Rada Toksikol. 2020 Oct 6;71(3):211-222. doi: 10.2478/aiht-2020-71-3473. PMID: 33074175; PMCID: PMC7968500. 5: Whitlock SE, Pereira MG, Lane J, Sleep D, Shore RF, Arnold KE. Detecting fluoxetine and norfluoxetine in wild bird tissues and feathers. Environ Int. 2019 May;126:193-201. doi: 10.1016/j.envint.2019.01.083. Epub 2019 Feb 22. PMID: 30802636. 6: Rodrigues P, Cunha V, Oliva-Teles L, Ferreira M, Guimarães L. Norfluoxetine and venlafaxine in zebrafish larvae: Single and combined toxicity of two pharmaceutical products relevant for risk assessment. J Hazard Mater. 2020 Dec 5;400:123171. doi: 10.1016/j.jhazmat.2020.123171. Epub 2020 Jun 17. PMID: 32593945. 7: Hiemke C, Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther. 2000 Jan;85(1):11-28. doi: 10.1016/s0163-7258(99)00048-0. PMID: 10674711. 8: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006–. Fluoxetine. 2021 Feb 15. PMID: 30000245. 9: Zindler F, Tisler S, Loerracher AK, Zwiener C, Braunbeck T. Norfluoxetine Is the Only Metabolite of Fluoxetine in Zebrafish (Danio rerio) Embryos That Accumulates at Environmentally Relevant Exposure Scenarios. Environ Sci Technol. 2020 Apr 7;54(7):4200-4209. doi: 10.1021/acs.est.9b07618. Epub 2020 Mar 13. PMID: 32167300. 10: Kim KI, Chung YC, Jin BK. Norfluoxetine Prevents Degeneration of Dopamine Neurons by Inhibiting Microglia-Derived Oxidative Stress in an MPTP Mouse Model of Parkinson's Disease. Mediators Inflamm. 2018 Dec 30;2018:4591289. doi: 10.1155/2018/4591289. PMID: 30692871; PMCID: PMC6332876.